| 标题 |
Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal for ImmunoTherapy of Cancer 作者:Amaury Daste; Xiuning Le; Amani Makkouk; Maulik Patel; Christophe Le Tourneau; et al 出版日期:2026-04-10 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)